Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new ramipril clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on ramipril
- Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions
Status: Completed, Condition Summary: Hypertension - Telmisartan Versus Ramipril After Acute Coronary Syndrome
Status: Recruiting, Condition Summary: Acute Coronary Syndrome; Myocardial Infarction; Coronary Disease - Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions
Status: Completed, Condition Summary: Hypertension - Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes
Status: Recruiting, Condition Summary: Metabolic Syndrome - Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria
Status: Completed, Condition Summary: Albuminuria - Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension
Status: Recruiting, Condition Summary: Hypertension - A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly
Status: Completed, Condition Summary: Hypertension - Use of Ramipril and Felodipine Combination Therapy in Hypertension: An Effectiveness Study With Local Patients in Argentina
Status: Completed, Condition Summary: Hypertension - Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor
Status: Active, not recruiting, Condition Summary: Glomerulonephritis - Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease
Status: Recruiting, Condition Summary: Peripheral Arterial Disease - Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives
Status: Completed, Condition Summary: Obesity; Hypertension - The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria
Status: Completed, Condition Summary: Diabetes; Proteinuria; Renin Angiotensin System - Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo
Status: Active, not recruiting, Condition Summary: Cardiovascular Diseases - Study Evaluating the Effect of Ramipril on Urinary Protein Excretion in Renal Transplant Patients Converted to Sirolimus
Status: Not yet recruiting, Condition Summary: Kidney Transplant; Kidney Transplantation; Renal Transplant - Gene Expression Profiling in Skeletal Muscle of Healthy Subjects Treated With Ramipril
Status: Recruiting, Condition Summary: Healthy - PRISMA = Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM
Status: Completed, Condition Summary: Hypertension - PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN
Status: Completed, Condition Summary: Hypertension - A Prospective, Randomized, Double-Blind, Double-Dummy, Forced Titration, Parallel Group Comparison, Multicenter Trial to Compare the Effects of Either Telmisartan (40-80 mg p.o. Once Daily) or Ramipril (5-10 mg p.o. Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 di
Status: Completed, Condition Summary: Diabetes Mellitus, Type 2; Hypertension - A 54 Week, Randomized, Double-Blind, Parallel-Group, Multicenter Study Evaluating the Long-Term Gastrointestinal (GI) Safety and Tolerability of Aliskiren (300 mg) Compared to Ramipril (10 mg) in Patients With Essential Hypertension
Status: Recruiting, Condition Summary: Hypertension - Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation
Status: Completed, Condition Summary: Atherosclerosis; Coronary Disease; Vasculitis - A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents
Status: Terminated, Condition Summary: Hypertension - FOCUS:Focus On Coronary Unstable Syndromes
Status: Completed, Condition Summary: Myocardial Ischemia - The RAS, Fibrinolysis and Cardiopulmonary Bypass
Status: Recruiting, Condition Summary: Coronary Artery Disease; Angiotensin Converting Enzyme; Angiotensin Receptor Blockers; Cardiopulmonary Bypass; Fibrinolysis; Inflammation - The Indian POLYCAP Study (TIPS)
Status: Recruiting, Condition Summary: Cardiovascular Diseases - Efficacy and Safety of Aliskiren +/- Ramipril When Added to Amlodipine in Hypertensive Patients With Metabolic Syndrome
Status: Not yet recruiting, Condition Summary: Hypertension With Metabolic Syndrome - Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg
Status: Recruiting, Condition Summary: Hypertension - Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.
Status: Completed, Condition Summary: Essential Hypertension - Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension
Status: Completed, Condition Summary: Hypertension - Ramipril in Rheumatoid Arthritis
Status: Completed, Condition Summary: Arthritis, Rheumatoid - Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
Status: Completed, Condition Summary: Hypertension; Blood Pressure, High